SCHEMBL1038296

SCHEMBL1038296

Cc1cc(C)c(C(=O)P(=O)(CC(=O)CC(=O)c2ccccc2)C(=O)c2c(C)cc(C)cc2C)c(C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.47
MEN1 O00255 6/20 0.47
RAB9A P51151 4/20 0.47
NPC1 O15118 2/20 0.46
SMN1; SMN2 Q16637 4/20 0.42
HPGD P15428 3/20 0.42
MAPT P10636 3/20 0.42
CYP3A4 P08684 2/20 0.42
KDM4E B2RXH2 1/20 0.42
ALOX15 P16050 1/20 0.42
CES1 P23141 1/20 0.42
MAPK1 P28482 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
LMNA P02545 4/20 0.40
POLB P06746 2/20 0.40
PTPN1 P18031 1/20 0.38
ERCC5 P28715 1/20 0.38
FEN1 P39748 1/20 0.38
TP53 P04637 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1038176 0.89 LMNA (0.47) KMT2AMEN1RAB9ANPC1SMN1; SMN2
SCHEMBL1035650 0.80 TAS1R3 (0.36) KMT2AMEN1SMN1; SMN2HPGDMAPT
SCHEMBL11058012 0.78 KMT2A (0.65) KMT2AMEN1RAB9ANPC1SMN1; SMN2
SCHEMBL1033908 0.77 TAS1R3 (0.35) KMT2AMEN1SMN1; SMN2HPGDMAPT
SCHEMBL1032446 0.76 GAA (0.42) KMT2AMEN1SMN1; SMN2HPGDMAPT
SCHEMBL1035049 0.75 NLRP3 (0.43) KMT2AMEN1SMN1; SMN2HPGDMAPT
SCHEMBL2710988 0.75 GAA (0.41) KMT2AMEN1SMN1; SMN2HPGDMAPT
SCHEMBL1035644 0.74 LMNA (0.39) KMT2AMEN1HPGDMAPK1LMNA
SCHEMBL7625246 0.74 LMNA (0.41) KMT2AMEN1RAB9ANPC1SMN1; SMN2
SCHEMBL3685553 0.73 KMT2A (0.43) KMT2AMEN1RAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814891-B1 BISACYLPHOSPHANES AND THEIR USE AS PHOTOINITIATORS; PROCESS FOR PREPARING ACYLPHOSPHANES BASF SE (DE) 2011-01-26 EP disclosed
US-7687657-B2 Process for preparing acylphosphanes and derivatives thereof CIBA SPECIALITY CHEMICALS CORPORATION (US) 2010-03-30 US disclosed
US-20080004464-A1 Process for Preparing Acylphosphanes and Derivatives Thereof IGM GROUP B.V. (NL) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004464-A1 Process for Preparing Acylphosphanes and Derivatives Thereof ME2, ME3, MEP1A KMT2A 490/4885MEN1 46/4885RAB9A 1163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.